HURA TuHURA Biosciences Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: HURA

Price (delayed)

$2.19

Market cap

$139.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.61

Enterprise value

$133.62M

?
Relative Growth: Rel. Growth: 13
Relative Strength: Rel. Strength: 57
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2
Highlights
TuHURA Biosciences's equity has soared by 135% YoY and by 11% from the previous quarter
The quick ratio has soared by 70% from the previous quarter and by 58% YoY
The debt has surged by 178% year-on-year but it has declined by 35% since the previous quarter
The net income fell by 32% YoY and by 2.9% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.delmarpharma.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of HURA

HURA stock price

How has the TuHURA Biosciences stock price performed over time
Intraday
3.3%
1 week
-6.81%
1 month
2.34%
1 year
-22.34%
YTD
189.41%
QTD
22.35%

Financial performance

How have TuHURA Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32.31M
Net income
-$30.92M
Gross margin
N/A
Net margin
N/A
TuHURA Biosciences's operating income has shrunk by 61% YoY
The net income fell by 32% YoY and by 2.9% QoQ

Price vs fundamentals

How does HURA's price correlate with its fundamentals

Growth

What is TuHURA Biosciences's growth rate over time

Valuation

What is TuHURA Biosciences stock price valuation
HURA P/E details
P/E
N/A
P/B
6
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TuHURA Biosciences's EPS has increased by 36% YoY and by 3.2% from the previous quarter
TuHURA Biosciences's equity has soared by 135% YoY and by 11% from the previous quarter
The P/B is 24% higher than the 5-year quarterly average of 4.7 and 21% higher than the last 4 quarters average of 4.8

Efficiency

How efficient is TuHURA Biosciences business performance
The return on invested capital has surged by 57% year-on-year and by 21% since the previous quarter
HURA's return on equity has surged by 53% year-on-year and by 14% since the previous quarter
HURA's ROA has soared by 52% YoY and by 10% QoQ

Dividends

What is HURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HURA.

Financial health

How did TuHURA Biosciences financials performed over time
The total assets has soared by 103% YoY and by 9% from the previous quarter
The quick ratio has soared by 70% from the previous quarter and by 58% YoY
The debt is 98% smaller than the equity
The debt has surged by 178% year-on-year but it has declined by 35% since the previous quarter
TuHURA Biosciences's equity has soared by 135% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.